دورية أكاديمية

Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.

التفاصيل البيبلوغرافية
العنوان: Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.
المؤلفون: Affolter, Annette, Samosny, Gerson, Heimes, Anne‐Sophie, Schneider, Johanna, Weichert, Wilko, Stenzinger, Albrecht, Sommer, Katharina, Jensen, Alexandra, Mayer, Arnulf, Brenner, Walburgis, Mann, Wolf J., Brieger, Jürgen
المصدر: Head & Neck; Apr2017, Vol. 39 Issue 4, p623-632, 10p
مصطلحات موضوعية: HEAD & neck cancer treatment, SORAFENIB, KINASE inhibitors, RADIATION-sensitizing agents, CANCER cells, SQUAMOUS cell carcinoma, THERAPEUTICS
مستخلص: Background Radioresistance is a common feature of head and neck squamous cell carcinoma (HNSCC). We previously showed that the irradiation- activated vascular endothelial growth factor (VEGF)-extracellular signal-regulated kinase (ERK)-axis is fundamental for the survival of resistant tumors. In this study, we examined if treatment with potent multikinase (MK) inhibitors, sorafenib and sunitinib, could radiosensitize tumor cells. Methods Cultured HNSCC cell lines were treated with inhibitors and subsequently irradiated. Radiosensitizing effects were functionally assessed by annexin-V apoptosis and clonogenic assays and confirmed by Western blot. Additionally, we surveyed human HNSCC tissue microarrays (TMAs) for activated ERK expression. Results Based on combination indexes, we found that combining irradiation with both inhibitors exerted strong and supra-additive antitumor effects on clonogenic survival. Kinase inhibition enhanced irradiation-induced apoptotic rates and inhibited postradiogenic phospho-ERK-expression. Patients with recurrent HNSCC displayed significantly lower extracellular signal-regulated kinase phosphorylation (pERK) levels than relapse-free patients. Conclusion We propose further evaluation of sorafenib and sunitinib as potential radiosensitizing agents in HNSCC treatment. © 2017 Wiley Periodicals, Inc. Head Neck 39: 623-632, 2017 [ABSTRACT FROM AUTHOR]
Copyright of Head & Neck is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10433074
DOI:10.1002/hed.24557